I cannot provide a reliable gene function summary for POMP based on the provided PubMed abstracts. The abstracts do not contain relevant information about POMP (proteasome maturation protein). The retrieved articles discuss clinical trials for acute lymphocytic leukemia using chemotherapy regimens that include 'POMP' maintenance therapy (6-mercaptopurine, vincristine, methotrexate, and prednisone) 1234, which is an acronym for a drug combination unrelated to the POMP gene. The remaining abstracts address embryo development, natural killer cell cryopreservation, relationship satisfaction, and motivation research—none of which pertain to proteasome maturation protein function. To provide an accurate summary of POMP's role as a molecular chaperone essential for proteasome assembly and its disease relevance in autoinflammatory syndromes and keratosis linearis with ichthyosis congenita, peer-reviewed literature specifically investigating the POMP gene and its protein product would be required.